why choose us

First received: November 21, 2022

Clinical Trial: Artificial Intelligence and Hepatocellular Carcinoma

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: HCC

Study Type: Observational


Official Title: Artificial Intelligence and Hepatocellular Carcinoma

Brief Summary: To identify new relevant biomarkers for HCC patients and their risk of recurrence. Radiomics data and computer-vision data will be explored for their ability to predict the presence of particular pathological signs of aggressiveness (microvascular invasion and satellitosis), and the prognosis after surgery.

Read more